Skip to main content
. 2012 Jan 24;2012:819636. doi: 10.1155/2012/819636

Figure 4.

Figure 4

The changes in the levels of serum IL-33 and sST2 in CHC patients with IFN treatment. Data are expressed as the mean values of individual participants from two separate experiments. The horizontal lines show the median. (a) The changes in the levels of serum IL-33 in CHC patients with IFN treatment; (b) the changes in the levels of serum sST2 in CHC patients with IFN treatment.